Sulfamerazinum

Sulfamerazinum Uses, Dosage, Side Effects, Food Interaction and all others data.

A sulfanilamide that is used as an antibacterial agent.

Sulfonamides act as competitive inhibitors of the enzyme dihydropteroate synthetase (DHPS), an enzyme involved in folate synthesis in bacteria.

Sulfamerazinum
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Sulfamerazinum
Generic	Sulfamerazine
Sulfamerazine Other Names	Sulfamerazina, Sulfamerazine, Sulfamerazinum, Sulfamethyldiazine, Sulphamerazine
Type
Formula	C₁₁H₁₂N₄O₂S
Weight	Average: 264.304 Monoisotopic: 264.068096338
Groups	Approved, Vet approved
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Sulfamerazinum is an antibacterial agent used in the treatment of various bacterial infections, such as bronchitis, prostatitis, and urinary tract infections.

A sulfanilamide that is used as an antibacterial agent. It can be used to treat bronchitis, prostatitis and urinary tract infections.

Sulfamerazinum is also used to associated treatment for these conditions: Abscesses, Conjunctivitis, Ear infection bacterial, Enteritis, Eye Infections, Eye discharge, Pneumonia, Streptococcal Sore Throat, Susceptible infections, Ulcers, Urinary Tract Infection, Urinary tract inflammation, Uterine infection

How Sulfamerazinum works

Sulfamerazinum is a sulfonamide drug that inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthetase (dihydrofolate synthetase). Sulfamerazinum is bacteriostatic in nature. Inhibition of dihydrofolic acid synthesis decreases the synthesis of bacterial nucleotides and DNA.

Toxicity

Sulfamerazinum may cause nausea, vomiting, diarrhea and hypersensitivity reactions. Hematologic effects such as anemia, agranulocytosis, thrombocytopenia and hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency may also occur. Sulfamethoxazole may displace bilirubin from albumin binding sites causing jaundice or kernicterus in newborns.